Evidence map›Paper›PMID 16928743›Full record

ArticleJournal of virology2006

Packaging determinants in the UL11 tegument protein of herpes simplex virus type 1.

Joshua S Loomis, Richard J Courtney, John W Wills

Abstract read
In one paragraph

Article in Journal of virology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joshua S LoomisDepartment of Microbiology and Immunology, The Pennsylvania State University College of Medicine, 500 University Dr., P.O. Box 850, Hershey, PA 17033, USA.
Richard J Courtney
John W Wills

Funding

VIRUSES AND CANCERT32CA060395 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MEYERS, CRAIG M · 1994 to 2021
$4.3M
Molecular Analysis of the Retroviral Budding MechanismR37CA047482 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI WILLS, JOHN W. · 2001 to 2005
$2.4M
STUDIES OF PURIFIED HERPES SIMPLEX VIRUS GLYCOPROTEINSR01CA042460 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI COURTNEY, RICHARD J · 1985 to 2005
$1.7M
GAG DOMAINS REQUIRED FOR RETROVIRUS ASSEMBLYR01CA047482 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI WILLS, JOHN W. · 1991 to 2000
$396k
ANALYSIS OF RETROVIRUS ASSEMBLY BY IN VITRO MUTAGENESISR29CA047482 · NCI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI WILLS, JOHN W. · 1987 to 1990
–
NCI NIH HHS CA42460NCI NIH HHS CA47482NCI NIH HHS CA60395NCI NIH HHS R01 CA042460NCI NIH HHS R01 CA047482NCI NIH HHS R37 CA047482NCI NIH HHS T32 CA060395
6 · The paper itself

Abstract

The UL11 gene of herpes simplex virus type 1 encodes a 96-amino-acid tegument protein that is myristylated, palmitylated, and phosphorylated and is found on the cytoplasmic faces of nuclear, Golgi apparatus-derived, and plasma membranes of infected cells. Although this protein is thought to play a role in virus budding, its specific function is unknown. Purified virions were found to contain approximately 700 copies of the UL11 protein per particle, making it an abundant component of the tegument. Moreover, comparisons of cell-associated and virion-associated UL11 showed that packaging is selective for underphosphorylated forms, as has been reported for several other tegument proteins. Although the mechanism by which UL11 is packaged is unknown, previous studies have identified several sequence motifs in the protein that are important for membrane binding, intracellular trafficking, and interaction with UL16, another tegument protein. To ascertain whether any of these motifs are needed for packaging, a transfection/infection-based assay was used in which mutant forms of the protein must compete with the wild type. In this assay, the entire C-terminal half of UL11 was found to be dispensable. In the N-terminal half, the sites of myristylation and palmitylation, which enable membrane-binding and Golgi apparatus-specific targeting, were found to be essential for efficient packaging. The acidic cluster motif, which is not needed for Golgi apparatus-specific targeting but is involved in recycling the protein from the plasma membrane and for the interaction with UL16, was found to be essential, too. Thus, something other than mere localization of UL11 to Golgi apparatus-derived membranes is needed for packaging. The critical factor is unlikely to be the interaction with UL16 because other mutants that fail to bind this protein (due to removal of the dileucine-like motif or substitutions with foreign acidic clusters) were efficiently packaged. Collectively, these results suggest that UL11 packaging is not driven by a passive mechanism but instead requires trafficking through a specific pathway.

Indexed as

Amino Acid MotifsAmino Acid SequenceAmino Acid SubstitutionAnimalsBase SequenceChlorocebus aethiopsDNA, ViralGenes, ViralGolgi ApparatusHerpesvirus 1, HumanMolecular Sequence DataMutagenesis, Site-DirectedPhosphorylationProtein TransportRatsRecombinant Fusion ProteinsDNA, ViralRecombinant Fusion ProteinsUL11 protein, herpesviridaeViral Structural Proteins

Identifiers

PMID16928743
PMCPMC1641780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.